Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 19/20 | 0.51 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14198125 | 0.88 | PPARG (0.53) | PPARGTP53SMN1; SMN2 | |
| SCHEMBL6703328 | 0.87 | PPARG (0.55) | PPARGTP53SMN1; SMN2 | |
| SCHEMBL6700640 | 0.86 | PPARG (0.53) | PPARGTP53SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL6697808 | 0.86 | PPARG (0.55) | PPARGTP53SMN1; SMN2 | |
| SCHEMBL6697787 | 0.86 | PPARG (0.54) | PPARGTP53SMN1; SMN2 | |
| SCHEMBL16366773 | 0.83 | PPARG (0.53) | PPARGTP53SMN1; SMN2 | |
| SCHEMBL6700207 | 0.82 | PPARG (0.54) | PPARGTP53SMN1; SMN2 | |
| SCHEMBL14159382 | 0.80 | PPARG (0.52) | PPARGTP53SMN1; SMN2 | |
| SCHEMBL6700128 | 0.80 | PPARG (0.45) | PPARG | |
| SCHEMBL6700598 | 0.80 | PPARG (0.57) | PPARGTP53SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019154958-A1 | USE OF MODULATORS OF NEET PROTEINS FOR THE TREATMENT OF INFECTION | ENYO PHARMA (FR) | 2019-08-15 | — | — | WO | disclosed |
| WO-2008028914-A1 | COMBINATION TREATMENT FOR DIABETES MELLITUS | NYCOMED GMBH (DE) | 2008-03-13 | — | — | WO | disclosed |